Illumina to cut $100M in fiscal 2025 costs

Illumina to cut $100M in costs to cope with China ban
The San Diego company also lowered its financial guidance for 2025 in response to China’s import restrictions.
Diagnostic Kit Maker Illumina To Cut $100 Million In Costs, Lowers 2025 Profit Outlook Amid China Trade Restrictions
Illumina slashes costs by $100 million after China bans its sequencers. The company lowers its 2025 EPS outlook and aims for high-single-digit growth by 2027.
Illumina to Cut $100 Million in Costs, Lowers Guidance Because of China Sales Ban
Illumina is reducing its forecast for this year’s financial performance and cutting $100 million in spending because China barred sales of the company’s gene-sequencing machines. San Diego-based Illumina is lowering its 2025 guidance to $4.
China Bans Illumina Sequencer Imports as Trade Tensions Rise
China banned the import of Illumina Inc. gene-sequencing machines as part of a wave of retaliatory trade measures in response to the US doubling tariffs on all Chinese goods.
China bans sales of Illumina DNA sequencers as Trump escalates global tariffs
Illumina has been barred from exporting its DNA sequencers to China, which closed | Illumina has been barred from exporting its DNA sequencers to China, which closed its doors to the company in response to the Trump administration expanding its tariffs on the country.
Illumina sees 2025 EPS of $4.50 after China ban, consensus $4.51
Illumina (ILMN) responded to the March 4 notice from the China Ministry of Commerce that the company is not permitted to export sequencing
China hits Illumina with import ban. What does that mean for the San Diego gene sequencer?
The Chinese government took its economic sanctions against San Diego-based Illumina a step further Tuesday by banning the ...
China Targets San Diego Biotech Firm in Broadening Blacklist
In a sign it is willing to go further in responding to President Trump’s tariffs, Beijing blocked more American companies ...
China bans imports of Illumina's gene sequencers right after Trump tariff action
China announced a ban on Tuesday on imports of genetic sequencers from U.S. medical equipment maker Illumina , just minutes ...
Illumina lowering 2025 earnings outlook to low end of range, WSJ says
Illumina (ILMN) is reducing its forecast for this year’s financial performance and cutting $100M in spending because China barred sales of its ...
San Diego Union-Tribune10d
Illumina cuts workforce at San Diego headquarters
Illumina recorded about $4.37 billion in total revenue during the 2024 fiscal year, down about 3% from the previous year.
What Makes Illumina (ILMN) an Attractive Opportunity?
Brown Advisors, an investment management company, released its “Brown Advisors Global Leaders Strategy” fourth quarter 2024 ...